Browse Title Index


 
Issue Title
 
Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer Abstract   PDF
M. Fakih, R. Wong
 
Vol 16, No 5 (2009) Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer Details   PDF
J. Gaulin, R. Kotb, E. Turcotte, G. Bérard, G. Schmutz, B. Sawan, P. Beauregard
 
Vol 17, No 1 (2010) EGFR overexpression in squamous cell carcinoma of the penis Abstract   PDF
N. Lavens, R. Gupta, L.A. Wood
 
Vol 19, No 1 (2012) EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions Abstract   PDF   HTML
B. Melosky
 
Vol 19, No 2 (2012) EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer Abstract   PDF   HTML
S. Kamel-Reid, G. Chong, D.N. Ionescu, A.M. Magliocco, A. Spatz, M. Tsao, X. Weng, S. Young, T. Zhang, D. Soulieres
 
Vol 25, No 5 (2018) Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients Abstract   PDF   HTML
Y. Sun, X. L.. Zhang, Q. F. Mao, Y. H. Liu, L. Kong, M.H. Li
 
Vol 16, No 2 (2009) Electrochemotherapy of tumors Abstract   PDF
Marko Snoj
 
Vol 18, No 1 (2011) E-Manuscript Article Summaries Details   PDF   HTML
Various Authors
 
Vol 18, No 2 (2011) E-Manuscript Article Summaries Details   PDF   HTML
Various Authors
 
Vol 18, No 3 (2011) E-Manuscript Article Summaries Details   PDF   HTML
Various Authors
 
Vol 18, No 4 (2011) E-manuscript Article Summaries Details   PDF   HTML
Amanda Shand
 
Vol 18, No 5 (2011) E-manuscript Article Summaries Details   PDF   HTML
Various Authors
 
Vol 18, No 6 (2011) E-manuscript article summaries Abstract   PDF   HTML
Current Oncology
 
Vol 19, No 1 (2012) E-manuscript Article Summaries Abstract   PDF   HTML
Multiple Authors
 
Vol 19, No 2 (2012) E-manuscript article summaries Abstract   PDF   HTML
Various Authors
 
Vol 23, No 6 (2016) Emerging therapies for the treatment of relapsed or refractory follicular lymphoma Abstract   PDF   HTML
D. MacDonald, A. Prica, S. Assouline, A. Christofides, T. Lawrence, L.H. Sehn
 
Vol 18, No 4 (2011) Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey Abstract   PDF   HTML
S. Verma, L. Provencher, R. Dent
 
Vol 22, No 6 (2015) Enablers and barriers in delivery of a cancer exercise program: the Canadian experience Abstract   PDF   HTML
D. Santa Mina, A. Petrella, K.L. Currie, K. Bietola, S.M.H. Alibhai, J. Trachtenberg, P. Ritvo, A.G. Matthew
 
Vol 17, No 6 (2010) Encouraging data out of the 2010 Congress of the European Society for Medical Oncology with respect to non-small-cell lung cancer Details   PDF
V. Hirsh
 
Vol 25, No 4 (2018) Endocrine therapy for breast cancer in the primary care setting Abstract   PDF   HTML
A. Awan, A. Esfahani
 
Vol 17, No 5 (2010) Endocrine therapy for male breast cancer: rates of toxicity and adherence Abstract   PDF
H. Visram, F. Kanji, S. F. Dent
 
Vol 20, No 1 (2013) Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement Abstract   PDF   HTML
K.I. Pritchard, K.A. Gelmon, D. Rayson, L. Provencher, Marc Webster, D. McLeod, S. Verma
 
Vol 17, No 6 (2010) Endometrioid ovarian carcinoma benefits from aromatase inhibitors: case report and literature review Abstract   PDF
Y. Pan, M.S. Kao
 
Vol 25, No 4 (2018) Engaging cancer patients in clinical practice guideline development: a pilot study Abstract   PDF   Supplemental Material   HTML
M.C. Brouwers, M. Vukmirovic, K. Spithoff, C. Zwaal, S. McNair, N. Peek
 
Vol 22, No 4 (2015) Enhancing access to cancer care for the Inuit Abstract   PDF   HTML
P. Doering, C. DeGrasse
 
Vol 17, No 3 (2010) Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer Abstract   PDF
C. Cripps, E. Winquist, M. C. Devries, D. Stys-Norman, R. Gilbert
 
Vol 25, No 4 (2018) Erratum: Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada Abstract   PDF   HTML
A. Chua, A. Perrin, J.F. Ricci, M.P. Neary, M. Thabane
 
Vol 19, No 3 (2012) Erratum: Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls Details   PDF   HTML
J. Pereira
 
Vol 21, No 6 (2014) Erratum: Salpingectomy to prevent ovarian cancer Abstract   PDF   HTML
S.A. Narod
 
Vol 22, No 2 (2015) Erratum: Tumour inflammatory response: adding fuel to the fire? Abstract   PDF   HTML
M. Valdes, M.R. Chasen
 
Going Beyond Efficacy Erythropoiesis Stimulating Agents: Benefits/Risks in Supportive Care of Cancer Abstract   PDF
Barbara L. Melosky
 
Vol 22, No 2 (2015) Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec Abstract   PDF   HTML
A.L. Smith, C. Bascuñana, A. Hall, A. Salman, A.Z. Andrei, A. Volenik, H. Rothenmund, D. Ferland, D. Lamoussenery, A.S. Kamath, R. Amre, D. Caglar, Z.H. Gao, D.G. Haegert, Y. Kanber, R.P. Michel, G. Omeroglu-Altinel, J. Asselah, N. Bouganim, P. Kavan, G. Arena, J. Barkun, P. Chaudhury, S. Gallinger, W.D. Foulkes, A. Omeruglu, P. Metrakos, G. Zogopoulos
 
Vol 18, No 5 (2011) Establishing a multicentre clinical research network: lessons learned Abstract   PDF   HTML
N. A. Hagen, C. R. Stiles, P. D. Biondo, G. G. Cummings, R. L. Fainsinger, D. E. Moulin, J. L. Pereira, R. Spice
 
Vol 23, No 3 (2016) Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario Abstract   PDF   HTML
J.H.E Yong, T. McGowan, R. Redmond-Misner, J. Beca, P. Warde, E. Gutierrez, J.S. Hoch
 
Vol 17, No 2 (2010) Estimating the national wage loss from cancer in Canada Abstract   PDF
R. B. Hopkins, R. Goeree, C. J. Longo
 
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada Abstract   PDF   HTML
P.A. Tang, A.E. Hay, C.J. O’Callaghan, N. Mittmann, C.R. Chambers, J.L. Pater, N.B. Leighl
 
Vol 13, No 2 (2006) ETHICAL GUIDEPOSTS TO CLINICAL TRIALS IN ONCOLOGY Details   PDF
Mark Bernstein
 
Vol 22, No 2 (2015) Ethnicity and breast cancer stage at diagnosis: an issue of health equity Abstract   PDF   HTML
A.K. Lofters
 
Vol 19, No 5 (2012) Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor–positive, one-to-three positive axillary lymph node, breast cancer Abstract   PDF   HTML
M.B. Hannouf, M. Brackstone, B. Xie, G.S. Zaric
 
Vol 17, No 4 (2010) Evaluating the impact on quality of life of chemoradiation in gastric cancer Abstract   PDF
Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintilie, J. Kim, J. Ringash
 
Vol 20, No 1 (2013) Evaluation of CancerChatCanada: a program of online support for Canadians affected by cancer Abstract   PDF   HTML
J. Stephen, A. Rojubally, K. MacGregor, D. McLeod, M. Speca, J. Taylor-Brown, K. Fergus, K. Collie, J. Turner, S. Sellick, G. Mackenzie
 
Vol 17, No 2 (2010) Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia Abstract   PDF
J. E. Corral, J. Quezada, E. J. Asturias
 
Vol 25, No 5 (2018) Evaluation of subcutaneous rituximab administration on Canadian systemic therapy suites Abstract   PDF   HTML
D. A. Stewart, J.S. Boudreault, B. Maturi, D. Boras, R. Foley
 
Vol 20, No 2 (2013) Evaluation of the clinical benefits of nanoparticle albumin-bound paclitaxel in women with metastatic breast cancer in British Columbia Abstract   PDF   HTML
A.E. Lohmann, C.H. Speers, S.K. Chia
 
Vol 25, No 4 (2018) Evaluation of the delivery of survivorship care plans for South Asian female breast cancer survivors residing in Canada Abstract   PDF   HTML
S. Singh-Carlson, F. Wong, G. Oshan
 
Vol 24, No 6 (2017) Evidence in medicine: math versus biology! Abstract   PDF   HTML
T. Younis, M. Thana, C. Skedgel
 
Vol 25, No 2 (2018) Evidence-based best practices for EGFR T790M testing in lung cancer in Canada Abstract   PDF   HTML
T. Stockley, C.A. Souza, P.K. Cheema, B. Melosky, S. Kamel-Reid, M.S. Tsao, A. Spatz, A. Karsan
 
Vol 21, No 3 (2014) Evidence-based guidance on venous thromboembolism in patients with solid tumours Abstract   PDF   HTML
M.A. Shea-Budgell, C.M.J. Wu, J.C. Easaw
 
Vol 21, No 2 (2014) Evidence-based guidelines for the use of tyrosine kinase inhibitors in adults with Philadelphia chromosome–positive or BCR-ABL–positive acute lymphoblastic leukemia: a Canadian consensus Abstract   PDF   HTML
S. Couban, L. Savoie, Y. Abou Mourad, B. Leber, M. Minden, R. Turner, V. Palada, N. Shehata, A. Christofides, S. Lachance
 
Vol 18, No 1 (2011) Evidence-based medicine: an analysis of prophylactic bilateral oophorectomy at time of hysterectomy for benign conditions Details   PDF   HTML
C. A. Larson
 
Vol 21, No 1 (2014) Examining cancer-risk profiles for the largest metropolitan areas across Canada Abstract   PDF   HTML
K. DeCaria, R. Rahal, T. Forte, G. Lockwood, J. Xu, H. Bryant, in collaboration with the System Performance Steering Committee and Technical Working Group
 
Vol 24, No 1 (2017) Examining the medical resource utilization and costs of relapsed and refractory chronic lymphocytic leukemia in Ontario Abstract   PDF   HTML
S. Hassan, S.J. Seung, M. C. Cheung, G. Fraser, B. Kuriakose, C. Trambitas, N. Mittmann
 
Vol 20, No 3 (2013) Examining the use of salpingectomy with hysterectomy in Canada Abstract   PDF   HTML
C. Sandoval, M. Fung-Kee-Fung, B. Gilks, K.J. Murphy, R. Rahal, H. Bryant
 
Vol 19, No 4 (2012) Excision of the primary tumour in patients with metastatic breast cancer: a clinical dilemma Abstract   PDF   HTML
S. Samiee, P. Berardi, N. Bouganim, L. Vandermeer, A. Arnaout, S. Dent, D. Mirsky, M. Chasen, J.M. Caudrelier, M. Clemons
 
Vol 20, No 4 (2013) Exercise and nutrition interventions in advanced lung cancer: a systematic review Abstract   PDF   HTML
C. Payne, P.J. Larkin, S. McIlfatrick, L. Dunwoody, J.H. Gracey
 
Vol 24, No 1 (2017) Exercise for people with cancer: a clinical practice guideline Abstract   PDF   HTML
R. Segal, C. Zwaal, E. Green, J.R. Tomasone, A. Loblaw, T. Petrella, The Exercise for People with Cancer Guideline Development Group
 
Vol 24, No 4 (2017) Exercise for people with cancer: a systematic review Abstract   PDF   HTML
R. Segal, C. Zwaal, E. Green, J. Tomasone, A. Loblaw, T. Petrella, the Exercise for People with Cancer Guideline Development Group
 
Vol 24, No 1 (2017) Exercise guidelines for cancer survivors: are fitness and quality-of-life benefits enough to change practice? Abstract   PDF   HTML
K.S. Courneya
 
Vol 19, No 3 (2012) Exercise in clinical cancer care: a call to action and program development description Abstract   PDF   HTML
D. Santa Mina, S.M.H. Alibhai, A.G. Matthew, C.L. Guglietti, J. Steele, J. Trachtenberg, P.G. Ritvo
 
Vol 16, No 3 (2009) Exosomes in Tumour Immunity Abstract   PDF
Aled Clayton, M. D. Mason
 
Vol 24, No 4 (2017) Experiences of Canadian oncologists with difficult patient deaths and coping strategies used Abstract   PDF   HTML
L. Granek, L. Barbera, O. Nakash, M. Cohen, M.K. Krzyzanowska
 
Vol 21, No 1 (2014) Exploring a “community of practice” methodology as a regional platform for large-scale collaboration in cancer surgery—the Ottawa approach Abstract   PDF   HTML
M. Fung-Kee-Fung, R.P. Boushey, R. Morash
 
Vol 25, No 5 (2018) Exploring cancer centres for physical activity and sedentary behaviour support for breast cancer survivors Abstract   PDF   HTML
A. J. Fong, J. M. Jones, G. Faulkner, C. M. Sabiston
 
Vol 17, No 4 (2010) Exploring cancer treatment decision-making by patients: a descriptive study Abstract   PDF
D. Stacey, L. Paquet, R. Samant
 
Vol 23, No 1 (2016) Expression and clinical significance of insulin-like growth factor 1 in lung cancer tissues and perioperative circulation from patients with non-small-cell lung cancer Abstract   PDF   HTML
S. Fu, H. Tang, Y. Liao, Q. Xu, C. Liu, Y. Deng, J. Wang, J. Wang, X. Fu
 
Vol 23, No 2 (2016) Expression of APPL1 is correlated with clinicopathologic characteristics and poor prognosis in patients with gastric cancer Abstract   PDF   HTML
J.S. Zhai, J.G. Song, C.H. Zhu, K. Wu, Y. Yao, N. Li
 
Vol 19 (2012): Oncology in China Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers Abstract   PDF   HTML
Y.L. Gong, C.J. Tao, M. Hu, J.F. Chen, X.F. Cao, G.M. Lv, P. Li
 
Vol 19, No 6 (2012) Extended adjuvant temozolomide with cis-retinoic acid for adult glioblastoma Abstract   PDF   HTML
M.W. Pitz, M. Lipson, B. Hosseini, P. Lambert, K. Guilbert, D. Lister, G. Schroeder, K. Jones, C. Mihalcioiu, D.D. Eisenstat
 
Vol 26, No 1 (2019) Extended venous thromboembolism prophylaxis after abdominopelvic cancer surgery: a retrospective review Abstract   PDF   HTML
M. Laureano, M. Ebraheem, M. Crowther
 
Vol 19, No 2 (2012) Extending neoadjuvant care through multi-disciplinary collaboration: proceedings from the fourth annual meeting of the Canadian Consortium for Locally Advanced Breast Cancer Abstract   PDF   HTML
J.-F. Boileau, C. Simmons, M. Clemons, S. Gandhi, J. Lee, S.K. Chia, M. Basik, L. Provencher, M. Untch, M. Brackstone
 
Vol 21, No 1 (2014) Extracellular–to–body cell mass ratio and subjective global assessment in head-and-neck cancers Abstract   PDF   HTML
T. Małecka-Massalska, A. Smolen, K. Morshed
 
Vol 21, No 2 (2014) Extracorporeal photopheresis in the management of graft-versus-host disease Abstract   PDF   HTML
C. Bredeson, R.B. Rumble, N.P. Varela, J. Kuruvilla, C.T. Kouroukis, Stem Cell Transplant Steering Committee
 
Vol 24, No 4 (2017) Extrahepatic metastasis of hepatocellular carcinoma arising from a hepatic adenoma without concurrent intrahepatic recurrence Abstract   PDF   HTML
N. Poddar, R. Ramlal, S. Ravulapati, S.M. Devlin, S. Gadani, C.I. Vidal, D. Cao, A.S. Befeler, J. Lai
 
Vol 17, No 5 (2010) Extramammary Paget disease: review of patients seen in a non-melanoma skin cancer clinic Abstract   PDF
J. Pang, D. Assaad, D. Breen, J. Fialkov, O. Antonyshyn, J. Balogh, M. Tsao, J. Kamra, G. Czarnota, E.A. Barnes
 
Vol 17, No 5 (2010) Extraskeletal myxoid chondrosarcoma of the heart and review of current literature Abstract   PDF
H. L. Geyer, N. Karlin
 
Vol 18, No 3 (2011) Eyelash trichomegaly secondary to panitumumab therapy Details   PDF   HTML
L. G.T. Morris, H. S. Hochster, M. D. DeLacure
 
Vol 23, No 1 (2016) Eye-witnessing cancer—an ever-challenging experience Abstract   PDF   HTML
S. Jurja
 
Vol 25, No 2 (2018) Factors affecting radiotherapy prescribing patterns in the post-mastectomy setting Abstract   PDF   HTML
T.A. Koulis, A. Dang, C. Speers, R.A. Olson
 
Vol 21, No 3 (2014) Factors associated with breast cancer mortality after local recurrence Abstract   PDF   HTML
R. Dent, A. Valentini, W. Hanna, E. Rawlinson, E. Rakovitch, P. Sun, S.A. Narod
 
Vol 21, No 4 (2014) Factors associated with delayed time to adjuvant chemotherapy in stage iii colon cancer Abstract   PDF   HTML
A. Chan, R. Woods, H. Kennecke, S. Gill
 
Vol 25, No 2 (2018) Factors associated with imaging in patients with early breast cancer after initial treatment Abstract   PDF   HTML
K. Enright, T. Desai, R. Sutradhar, A. Gonzalez, M. Powis, N. Taback, C.M. Booth, M.E. Trudeau, M.K. Krzyzanowska
 
Vol 21, No 4 (2014) Factors associated with publication of randomized phase iii cancer trials in journals with a high impact factor Abstract   PDF   HTML
P. Tang, G.R. Pond, S. Welch, E.X. Chen
 
Vol 26, No 1 (2019) Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study Abstract   PDF   HTML
A. L. Mahar, L. E. Davis, L. D. Bubis, Q. Li, R. Sutradhar, N. G. Coburn, L. Barbera
 
Vol 20, No 1 (2013) Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study Abstract   PDF   HTML
J. Kankesan, F.A. Shepherd, Y. Peng, G. Darling, G. Li, W. Kong, W.J. Mackillop, C.M. Booth
 
Vol 16, No 5 (2009) Factors influencing mammography screening in Canada: An integrative review of the literature Abstract   PDF
P. Montgomery, K. Hanson, D. Bakker, M. Conlon
 
Vol 26, No 1 (2019) Factors influencing the outcome of stereotactic radiosurgery in patients with five or more brain metastases Abstract   PDF   HTML
E. Hamel-Perreault, D. Mathieu, L. Masson-Cote
 
Vol 20, No 3 (2013) Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study Abstract   PDF   HTML
S.P. Krotneva, K.E. Reidel, A. Verma, N. Mayo, R. Tamblyn, A.N. Meguerditchian
 
Vol 26, No 1 (2019) Factors influencing the use by radiation therapists of cancer symptom guides: a mixed-methods study Abstract   PDF   HTML
C. Ludwig, J. Renaud, L. Barbera, M. Carley, C. Henry, L. Jolicoeur, C. Kuziemsky, A. Patry, D. Stacey
 
Vol 24, No 2 (2017) Factors influencing treatment selection and survival in advanced lung cancer Abstract   PDF   HTML
S. Tabchi, E. Kassouf, M. Florescu, M. Tehfe, N. Blais
 
Vol 18, No 6 (2011) Factors related to the implementation and use of an innovation in cancer surgery Abstract   PDF   HTML
R. Urquhart, J. Sargeant, G.A. Porter
 
Vol 20, No 3 (2013) Fallopian tube removal: “STIC-ing” it to ovarian cancer: what is the utility of prophylactic tubal removal? Abstract   PDF   HTML
T.J. Herzog, H.E. Dinkelspiel
 
Vol 21, No 2 (2014) FDG-PET in two cases of neurofibromatosis type 1 and atypical malignancies Abstract   PDF   HTML
P. de Blank, K. Cole, L. Kersun, A. Green, J.J. Wilkes, J. Belasco, R. Bagatell, L.C. Bailey, M.J. Fisher
 
Vol 17, No 2 (2010) Feasibility of administering zoledronic acid in palliative patients being cared for in the community: results of a pilot study Abstract   PDF
H. K. Marr, C. R. Stiles, M. A. Boyar, T. C. Braun, N. A. Hagen, C. Janzen, L. M. Whitten, J. L. Pereira
 
Vol 24, No 6 (2017) Feasibility of assessing patient health benefits and incurred costs resulting from early dysphagia intervention during and immediately after chemoradiotherapy for head-and-neck cancer Abstract   PDF   HTML
R. Martino, J. Ringash, L. Durkin, E. Greco, S. Hui Huang, W. Xu, C.J. Longo
 
Vol 17, No 2 (2010) Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice—a retrospective analysis Abstract   PDF
T. Vandenberg, J. Younus, S. Al-Khayyat
 
Vol 19, No 6 (2012) Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice—an updated analysis Abstract   PDF   HTML
J. Younus, T. Vandenberg, M. Jawaid, M.A. Jawaid
 
Vol 23, No 4 (2016) Fee-for-service cancer rehabilitation programs improve health-related quality of life Abstract   PDF   HTML
A.A. Kirkham, S.E. Neil-Sztramko, J. Morgan, S. Hodson, S. Weller, T. McRae, K.L. Campbell
 
Vol 26, No 1 (2019) Ferocious Beast Abstract   PDF   HTML
N. A. Rutkowski
 
Vol 22, No 4 (2015) Fertility preservation in reproductive-age women facing gonadotoxic treatments Abstract   PDF   HTML
J. Roberts, R. Ronn, N. Tallon, H. Holzer
 
Vol 19, No 3 (2012) Fertility risk discussions in young patients diagnosed with colorectal cancer Abstract   PDF   HTML
A. Kumar, A. Merali, G.R. Pond, K. Zbuk
 
501 - 600 of 1559 Items << < 1 2 3 4 5 6 7 8 9 10 > >>